Most Popular Science Stories of 2018
From sensory processing disorder to how CRISPR is being explored to bring new treatments to patients, these are the stories that most engaged our readers in 2018.
University of California San Francisco
Give to UCSFFrom sensory processing disorder to how CRISPR is being explored to bring new treatments to patients, these are the stories that most engaged our readers in 2018.
Scientists identified key ways Ebola, Dengue, and Zika viruses hijack the body’s cells, and they found at least one potential drug that can disrupt this process in human cells.
Thirty-five years after its launch, Ward 86 continues to be a global leader in HIV care and has significantly influenced milestones in treatment and prevention.
UC San Francisco, National Jewish Health and Centro de Neumología Pediátrica in Puerto Rico have been awarded nearly $10 million to address the root causes of asthma in children in Puerto Rico.
The Quantitative Biosciences Institute attracts investigators on the basis of the tools and techniques they employ, rather than the diseases they study.
Almost half of the nearly 10 million patients with active tuberculosis each year could potentially be cured with significantly shorter treatments than current guidelines recommend.
These results confirm that the HPV virus causes head and neck cancer by inactivating the same proteins that are mutated in smoking-induced cancer.
A group of researchers from the Gladstone Institutes, UCSF, and UC Berkeley used a systematic approach to get an entirely new look at the way tuberculosis infects people.
The journey from discovering and developing effective, precise medications to using them correctly and safely in patients is hardly fast and easy. Nor is it a straight shot. Scientists in the UCSF School of Pharmacy are challenging the status quo every step of the way.
Mayor Mark Farrell announced $4.2 million in additional funds for HIV/AIDS programs in San Francisco.
Infectious disease expert Charles Chiu explains the rise in Lyme disease cases, better diagnostic tests on the horizon and what you need to know to protect yourself from infection.
More than 100 members of the malaria research community in the Bay Area gathered to celebrate World Malaria Day on April 25 at Zuckerberg San Francisco General Hospital.
Treating young children in Sub-Saharan Africa with azithromycin, a safe, inexpensive, and widely used antibiotic, significantly reduced deaths of children under five.
A newly launched Lancet Commission on Malaria Eradication will convene experts from around the world to develop the first-ever roadmap to eradicate malaria.
Mike Reid, who has worked around the globe providing treatment for serious infectious diseases, is part of a growing effort to eliminate tuberculosis worldwide.
UCSF’s School of Medicine placed in the top five nationally in this year’s U.S. News & World Report survey of best graduate and professional schools. UCSF’s biomedical science PhD programs were among the top 10, and the School of Nursing was also highly ranked.
Sending community health workers door-to-door to look for sick kids in a rapidly urbanizing area of West Africa, and offering them free care, coincided with a dramatic drop in childhood mortality.
UCSF scientists have uncovered new mechanisms by which HIV hides in infected cells, resting in a latent state that evades the body’s immune system and preventing antiviral drugs from flushing it out.
The MEI is part of a group of partners that has been awarded a new contract by USAID to support the President’s Malaria Initiative’s Advancing the Progress of Malaria Service Delivery project in 28 countries.
A new UCSF study has shown that a cancer-killing (“oncolytic”) virus currently in clinical trials may function as a cancer vaccine.
An international team of researchers has shown that two different compounds, can safely and effectively be added to treatment regimens to block transmission of the most common form of malaria in Africa.
UCSF’s Charles Chiu, MD, PhD, an expert in infectious diseases, answered some questions about this year’s flu season.
Much of San Francisco’s progress in fighting new HIV infections can likely be contributed to Getting to Zero – a citywide collaboration to end HIV transmission that was co-founded by UCSF.